Brainstem Stroke Clinical Trials

7 recruitingLast updated: May 21, 2026

There are 7 actively recruiting brainstem stroke clinical trials across 3 countries. Studies span Not Applicable, Phase 2. Top locations include Shanghai, Shanghai Municipality, China, Boston, Massachusetts, United States, Chicago, Illinois, United States. Updated daily from ClinicalTrials.gov.


Brainstem Stroke Trials at a Glance

7 actively recruiting trials for brainstem stroke are listed on ClinicalTrialsFinder across 6 cities in 3 countries. The largest study group is Not Applicable with 6 trials, with the heaviest enrollment activity in Shanghai, Boston, and Chicago. Lead sponsors running brainstem stroke studies include Johns Hopkins University, Leigh R. Hochberg, MD, PhD., and Huashan Hospital.

Browse brainstem stroke trials by phase

About Brainstem Stroke Clinical Trials

Looking for clinical trials for Brainstem Stroke? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Brainstem Stroke trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Brainstem Stroke clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Not Applicable

Cortical Recording and Stimulating Array Brain-Machine Interface

Spinal Cord InjuryBrainstem StrokeBrachial Plexus Injury+2 more
Michael Boninger30 enrolled2 locationsNCT01894802
Recruiting
Not Applicable

RAINBOW-ICH Trial of AI Guided Minimally Invasive Neurosurgery for ICH

Intraventricular hemorrhageBrainstem StrokeBasal Ganglia Hemorrhage+1 more
Second Affiliated Hospital, School of Medicine, Zhejiang University1,000 enrolled1 locationNCT07205263
Recruiting
Not Applicable

Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Tablet-01)

ALSSpinal Cord InjuriesCervical Spinal Cord Injury+2 more
Leigh R. Hochberg, MD, PhD.2 enrolled1 locationNCT06511934
Recruiting
Not Applicable

Investigation on the Cortical Communication System

Traumatic Brain InjuryNeuromuscular Diseaseslocked-in Syndrome+1 more
UMC Utrecht2 enrolled1 locationNCT06207591
Recruiting
Not Applicable

Investigation on the Cortical Communication (CortiCom) System

Amyotrophic Lateral Sclerosislocked-in SyndromeBrainstem Stroke+1 more
Johns Hopkins University3 enrolled1 locationNCT03567213
Recruiting
Not Applicable

Research on Wireless Brain Implant System for General Control of External Devices

Amyotrophic Lateral SclerosisSpinal Cord InjuryComplete or Incomplete Paraplegia/quadriplegia+2 more
Shanghai StairMed Technology Co., Ltd.4 enrolled1 locationNCT06829212
Recruiting
Phase 2

Hemorrhagic Brainstem Cavernous Malformations Treatment With Sirolimus: aSingle Centre, Randomized, Placebo-controlled Pilot Trial

Intracerebral HemorrhageBrainstem StrokeCavernous Malformations
Huashan Hospital75 enrolled2 locationsNCT06091332